Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors (Q27742255)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors	scientific article

Statements

scholarly article

0 references

Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors (English)

0 references

molecular design

0 references

1 reference

based on heuristic

inferred from title

Jörg Stürzebecher

4

object named as

J Stürzebecher

0 references

author name string

M Renatus

1

0 references

W Bode

2

0 references

R Huber

3

0 references

D Prasa

5

0 references

S Fischer

6

0 references

U Kohnert

7

0 references

M T Stubbs

8

0 references

language of work or name

0 references

publication date

29 August 1997

0 references

Journal of Biological Chemistry

0 references

272

0 references

35

0 references

21713-9

0 references

The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Serpin-resistant mutants of human tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Origins of the specificity of tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Structure of human des(1-45) factor Xa at 2.2 A resolution

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

The refined 1.9-Å X-ray crystal structure of d-Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: Structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

AMoRe: an automated package for molecular replacement

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

The CCP4 suite: programs for protein crystallography

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

PROCHECK: a program to check the stereochemical quality of protein structures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Mapping of the catalytic site of CHO‐t‐PA and the t‐PA variant BM 06.022 by synthetic inhibitors and substrates

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

The crystal structure of the catalytic domain of human urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Accurate bond and angle parameters for X-ray protein structure refinement

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Substrate specificity of tissue type plasminogen activator. Characterization of the fibrin independent specificity of t-PA for plasminogen

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Distinct mechanisms contribute to stringent substrate specificity of tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Making tissue-type plasminogen activator more fibrin specific

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.35.21713

21 January 2018

Identifiers

10.1074/JBC.272.35.21713

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27742255&oldid=1980419368"